Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Curr Opin Organ Transplant. 2021 Jun 1;26(3):282-289. doi: 10.1097/MOT.0000000000000872.
There is a critical shortage of organs in cardiac transplantation. Recent advancements in both organ allocation and donor utilization have intended to address this shortage and optimally allocate allografts. This review evaluates several important aspects of recipient and donor management. For recipients, the focus is placed on the evolving mechanical circulatory support population and its bidirectional impact on organ allocation. From the donor standpoint, organ utilization is assessed with respect to increasing access to previously unused allografts.
Implementation of the new heart allocation system in the United States has better stratified waitlist candidates by illness acuity. Compared to the prior system, those requiring venoarterial extracorporeal membrane oxygenation support are less likely to die on the waitlist, although conflicting data exists whether this has improved their posttransplant survival. The use of pretransplant intra-aortic balloon pumps has markedly increased, whereas transplantation of patients with dischargeable left ventricular assist devices has decreased. Although some studies have reported inferior short- to mid-term posttransplant survival in the new system compared to its predecessor, others report similar outcomes.Several recent advancements in donor utilization have also been noted. Coinciding with the global increase in drug overdose deaths, efforts have been made to increase use of these donors who are frequently considered 'increased risk' and are hepatitis C-positive. Grafts from these donors appear safe to use. These, alongside donation after circulatory death donors, represent potentially underutilized populations that may effectively expand the donor pool.
Recent changes in organ allocation, alongside efforts to expand the donor pool, have attempted to improve cardiac allograft utilization and reduce the imbalance between organ supply and demand. Ongoing monitoring and continuous re-evaluation of these efforts will help guide future practice.
心脏移植中存在严重的器官短缺问题。在器官分配和供者利用方面的最新进展旨在解决这一短缺问题,并使同种异体移植物得到最佳分配。这篇综述评估了受者和供者管理的几个重要方面。对于受者,重点是不断发展的机械循环支持人群及其对器官分配的双向影响。从供者的角度来看,评估了增加以前未使用过的同种异体移植物的利用情况。
美国新的心脏分配系统的实施更好地根据疾病严重程度对候补名单上的候选人进行分层。与之前的系统相比,需要静脉动脉体外膜肺氧合支持的患者在候补名单上死亡的可能性较低,尽管关于这是否提高了他们的移植后存活率存在相互矛盾的数据。在移植前使用主动脉内球囊泵的情况明显增加,而使用可出院的左心室辅助装置的患者移植减少。尽管一些研究报告新系统的短期至中期移植后存活率低于其前身,而其他研究则报告了类似的结果。最近在供者利用方面也取得了一些进展。随着全球药物过量死亡人数的增加,人们努力增加使用这些通常被认为是“高风险”且丙型肝炎阳性的供者。这些供者的移植物似乎可以安全使用。这些供者,以及循环死亡后供者,代表了潜在未充分利用的人群,可能有效地扩大供者群体。
器官分配的最新变化,以及扩大供者群体的努力,旨在提高心脏同种异体移植物的利用率,减少器官供需之间的不平衡。对这些努力的持续监测和不断重新评估将有助于指导未来的实践。